OXIS INTERNATIONAL 8-K

Company

GT Biopharma, Inc.

Filed

April 15, 2003

Period of Report

April 8, 2003

Accession Number

0001157523-03-001042

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →